• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why EngageSmart Shares Are Trading Higher By Around 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    10/23/23 1:54:47 PM ET
    $ABL
    $ACON
    $AGFY
    $AJX
    Investment Managers
    Finance
    Medical Specialities
    Health Care
    Get the next $ABL alert in real time by email

    Gainers

    INVO Bioscience, Inc. (NASDAQ:INVO) jumped 375% to $2.57 as the company agreed to acquire NAYA Biosciences in an all-stock transaction.

    LumiraDx Limited (NASDAQ:LMDX) shares climbed 187.4% to $0.25 after the company reported a strategic collaboration with AstraZeneca and Everton in the Community to set up England’s first community-based heart and lung screening hub.

    Akumin Inc. (NASDAQ:AKU) shares climbed 125% to $0.3279 after the company reached an agreement with Stonepeak to become a private company.

    Textainer Group Holdings Limited (NYSE:TGH) shares gained 44.5% to $49.33 after the company agreed to be acquired by Stonepeak for $7.4 billion.

    Twin Ridge Capital Acquisition Corp. (NYSE:TRCA) climbed 17.7% to $8.11.

    Bright Green Corporation (NASDAQ:BGXX) rose 17.6% to $0.4156.

    Navios Maritime Holdings Inc. (NYSE:NM) gained 17.2% to $2.21. N Logistics Holdings announced plans to acquire all outstanding shares of common stock of Navios Maritime Holdings not already owned by NLHC for $2.28 per share.

    Motus GI Holdings, Inc. (NASDAQ:MOTS) gained 16.2% to $0.5576.

    TeraWulf Inc. (NASDAQ:WULF) rose 16% to $1.2775

    FLJ Group Limited (NASDAQ:FLJ) jumped 15.8% to $0.3323.

    NOVONIX Limited (NASDAQ:NVX) climbed 15.4% to $2.10

    The Alkaline Water Company Inc. (NASDAQ:WTER) shares rose 14.6% to $0.2290 after falling 14% on Friday.

    Nexalin Technology, Inc. (NASDAQ:NXL) surged 13.6% to $0.3580.

    Farfetch Limited (NYSE:FTCH) rose 13% to $1.7850.

    EngageSmart, Inc. (NYSE:ESMT) gained 12.1% to $22.65 after the company announced it would be acquired by Vista Equity Partners for $23 per share.

    Digital Brands Group, Inc. (NASDAQ:DBGI) rose 11.2% to $5.36.

    Abacus Life, Inc. (NASDAQ:ABL) climbed 8.4% to $6.81.

    Riot Platforms, Inc. (NASDAQ:RIOT) shares gained 7.6% to $9.55 following a spike in Bitcoin.

    Hut 8 Mining Corp. (NASDAQ:HUT) gained 7% to $1.9889 amid a rise in Bitcoin.

    Losers

    Revolution Medicines, Inc. (NASDAQ:RVMD) fell 43.2% to $15.85 after the company announced it presented clinical activity and safety data from its Phase 1/1b trial of RMC-6236.

    Li-Cycle Holdings Corp. (NYSE:LICY) shares fell 42.4% to $1.3087 after the company announced plans to halt construction work on its Rochester Hub project, pending completion of a comprehensive review of the go-forward strategy for the project..

    Apollomics, Inc. (NASDAQ:APLM) dipped 38% to $1.08 after the company announced the presentation of vebreltinib efficacy and safety data from the KUNPENG clinical trial at ESMO 2023.

    XORTX Therapeutics Inc. (NASDAQ:XRTX) fell 36.6% to $0.4050 after jumping more than 100% on Friday.

    Aclarion, Inc. (NASDAQ:ACON) fell 36% to $0.3597. Aclarion signed a LOI with ATEC to advance commercialization of Nociscan.

    Great Ajax Corp. (NYSE:AJX) declined 33% to $4.26 after the company and Ellington Financial announced the mutual termination of their merger agreement.

    Spectaire Holdings Inc. (NASDAQ:SPEC) fell 27.5% to $3.60.

    Troika Media Group, Inc. (NASDAQ:TRKA) shares fell 27.3% to $0.8001 after reporting financial results for the quarter ended June 30, 2023.

    WANG & LEE GROUP, Inc. (NASDAQ:WLGS) fell 26.3% to $0.56 after gaining over 38% on Friday.

    Bruush Oral Care Inc. (NASDAQ:BRSH) declined 23.7% to $0.38.

    Agrify Corporation (NASDAQ:AGFY) fell 23% to $1.86.

    MMTec, Inc. (NASDAQ:MTC) fell 21.1% to $1.1350.

    Ambrx Biopharma Inc. (NASDAQ:AMAM) declined 20.9% to $6.66. Ambrx announced ARX517, a PSMA-targeted ADC, demonstrates 52% PSA50 (≥50% Reduction) and a highly differentiated safety and PK profile in patients with mCRPC, who progressed on multiple FDA-approved treatments.

    Ryvyl Inc. (NASDAQ:RVYL) fell 20% to $2.31.

    C4 Therapeutics, Inc. (NASDAQ:CCCC) declined 18.2% to $1.53.

    FaZe Holdings Inc. (NASDAQ:FAZE) shares fell 17.4% to $0.1643. GameSquare Holdings and FaZe Holdings recently entered into a definitive agreement pursuant to which GameSquare will acquire FaZe Clan in an arm's length all-stock transaction.

    Erayak Power Solution Group Inc. (NASDAQ:RAYA) fell 16.4% to $0.7101.

    Biocept, Inc. (NASDAQ:BIOC) fell 16.3% to $0.4730.

    Harpoon Therapeutics, Inc. (NASDAQ:HARP) shares fell 15.8% to $5.80 after the company. Harpoon announced a private placement of PIPE equity of up to $150 million. The company disclosed announced updated data from a trial evaluating its cancer drug.

    Falcon's Beyond Global, Inc. (NASDAQ:FBYD) dipped 15.6% to $14.57.

    FMC Corporation (NYSE:FMC) fell 12.7% to $58.52 after the company updated its third-quarter and FY23 outlook.

    VinFast Auto Ltd. (NASDAQ:VFS) fell 12.3% to $4.72. The company recently entered into a standby equity agreement with YA LL PN for an aggregate subscription amount of up to $1 billion.

    ContraFect Corporation (NASDAQ:CFRX) shares fell 11.9% to $0.3172 in pre-market trading after declining 10% on Friday. The company recently reported FDA clearance of CF-370 IND application to proceed with Phase 1 clinical study.

    Catalyst Biosciences, Inc. (NASDAQ:CBIO) fell 11.7% to $0.4414 in pre-market trading after climbing around 25% on Friday.

    Intelligent Bio Solutions Inc. (NASDAQ:INBS) fell 10.5% to $0.2417 in pre-market trading after gaining 10% on Friday.

    Golden Sun Education Group Limited (NASDAQ:GSUN) shares fell 10.1% to $0.4691 after declining 5% on Friday.

    Okta, Inc. (NASDAQ:OKTA) declined 8.9% to $68.87 on continued downward momentum after a threat actor breached its support system and viewed certain customer files. Also, Keybanc maintained an Overweight rating on the stock but lowered its price target from $106 to $95.

    World Acceptance Corporation (NASDAQ:WRLD) fell 8% to $102.50 after BMO Capital maintained an Underperform rating on the stock and lowered its price target from $58 to $56.

    NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) declined 7.4% to $6.50. NewAmsterdam Pharma named Ian Somaiya as Chief Financial Officer.

    Now Read This: Bitcoin Tops This Key Level; Fantom Emerges As Top Gainer

    Get the next $ABL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABL
    $ACON
    $AGFY
    $AJX

    CompanyDatePrice TargetRatingAnalyst
    Okta Inc.
    $OKTA
    3/19/2026$100.00Outperform
    Macquarie
    NewAmsterdam Pharma Company N.V.
    $NAMS
    3/18/2026$57.00Buy
    Truist
    Revolution Medicines Inc.
    $RVMD
    3/16/2026Buy
    Jefferies
    Okta Inc.
    $OKTA
    3/6/2026$97.00Market Perform → Outperform
    BMO Capital Markets
    Okta Inc.
    $OKTA
    3/3/2026$76.00Equal Weight
    Wells Fargo
    Revolution Medicines Inc.
    $RVMD
    2/27/2026$145.00Buy
    UBS
    Okta Inc.
    $OKTA
    2/26/2026$90.00 → $83.00Market Perform
    BMO Capital Markets
    TeraWulf Inc.
    $WULF
    2/9/2026$37.00Overweight
    Morgan Stanley
    More analyst ratings

    $ABL
    $ACON
    $AGFY
    $AJX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    Digital Brands Group Reports Initial Findings from AI Brand Protection Deployment with Herschel Supply Co.

    Digital Brands Group, Inc. (NASDAQ:DBGI) (the "Company," "Digital Brands Group" or "DBG") today announced initial findings from its AI powered brand protection deployment with Herschel Supply Co., following the previously announced partnership supported by SECUR3D Inc. Following initial deployment, Digital Brands Group has received its first findings report from the AI-driven monitoring system. During the initial search phase, the platform identified counterfeit activity representing more than $500,000 in estimated lost revenue exposure attributable to unauthorized listings and brand misuse across global digital marketplaces. The findings highlight the scale and measurable financial imp

    3/19/26 8:40:00 AM ET
    $DBGI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    Aclarion Publishes CEO Shareholder Letter Highlighting Strategic Progress and 2026 Catalysts

    Pursuing reimbursement coverage from one or more regional insurance providers in the United States as an important step toward broader payer adoption Initial CLARITY trial readout in Q4 2026 Strong Balance Sheet with Cash Runway into 2028 BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today the publication of a Shareholder Letter from Chief Executive Officer Brent Ness providing an update on the company's

    3/19/26 6:00:00 AM ET
    $ACON
    Medical Specialities
    Health Care

    $ABL
    $ACON
    $AGFY
    $AJX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Chen Hong-Jung

    3 - Apollomics Inc. (0001944885) (Issuer)

    3/18/26 6:52:25 PM ET
    $APLM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Chu Yi-An

    3 - Apollomics Inc. (0001944885) (Issuer)

    3/18/26 6:46:11 PM ET
    $APLM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 3 filed by new insider Huang Ya-Chi

    3 - Apollomics Inc. (0001944885) (Issuer)

    3/18/26 6:46:13 PM ET
    $APLM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABL
    $ACON
    $AGFY
    $AJX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Macquarie initiated coverage on Okta with a new price target

    Macquarie initiated coverage of Okta with a rating of Outperform and set a new price target of $100.00

    3/19/26 8:26:35 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    Truist initiated coverage on NewAmsterdam Pharma with a new price target

    Truist initiated coverage of NewAmsterdam Pharma with a rating of Buy and set a new price target of $57.00

    3/18/26 3:54:27 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Jefferies resumed coverage on Revolution Medicines

    Jefferies resumed coverage of Revolution Medicines with a rating of Buy

    3/16/26 9:35:47 AM ET
    $RVMD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ABL
    $ACON
    $AGFY
    $AJX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bucella Michael C. bought $19,950 worth of shares (1,338 units at $14.91), increasing direct ownership by 0.49% to 273,552 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/13/26 5:49:13 PM ET
    $WULF
    EDP Services
    Technology

    Director Bucella Michael C. bought $30,071 worth of shares (2,085 units at $14.42), increasing direct ownership by 0.77% to 272,214 units (SEC Form 4)

    4 - TERAWULF INC. (0001083301) (Issuer)

    3/9/26 7:31:19 PM ET
    $WULF
    EDP Services
    Technology

    Director Barry Michael F bought $249,938 worth of shares (18,072 units at $13.83), increasing direct ownership by 1,157% to 19,634 units (SEC Form 4)

    4 - FMC CORP (0000037785) (Issuer)

    3/5/26 12:11:06 PM ET
    $FMC
    Major Chemicals
    Industrials

    $ABL
    $ACON
    $AGFY
    $AJX
    SEC Filings

    View All

    SEC Form 425 filed by Ryvyl Inc.

    425 - RYVYL Inc. (0001419275) (Subject)

    3/19/26 6:05:24 AM ET
    $RVYL
    Professional Services
    Consumer Discretionary

    Ryvyl Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - RYVYL Inc. (0001419275) (Filer)

    3/19/26 6:01:32 AM ET
    $RVYL
    Professional Services
    Consumer Discretionary

    SEC Form 8-K filed by Digital Brands Group Inc.

    8-K - Digital Brands Group, Inc. (0001668010) (Filer)

    3/18/26 5:29:16 PM ET
    $DBGI
    Clothing/Shoe/Accessory Stores
    Consumer Discretionary

    $ABL
    $ACON
    $AGFY
    $AJX
    Financials

    Live finance-specific insights

    View All

    Aclarion, Inc. Adopts Limited Duration Stockholder Rights Plan

    BROOMFIELD, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. (NASDAQ:ACON, ACONW)) ("Aclarion" or the "Company") today announced that its Board of Directors (the "Board") has unanimously adopted a limited duration stockholder rights plan (the "Rights Plan"). The Rights Plan is effective immediately and expires in one year. The Rights Plan is intended to enable all stockholders to realize the long-term value of their investment in Aclarion. The Rights Plan is also intended to reduce the likelihood that any person or group gains control of the Company without paying all stockholders an appropriate control premium. The Rights Plan will help to ensure the Board has sufficient time to

    3/19/26 9:25:40 AM ET
    $ACON
    Medical Specialities
    Health Care

    VinFast Reports Preliminary and Unaudited Fourth Quarter and Full Year 2025 Financial Results

    SINGAPORE, March 16, 2026 /PRNewswire/ -- VinFast Auto Ltd. ("VinFast" or the "Company") (NASDAQ:VFS), a pure-play electric vehicle ("EV") manufacturer with the mission of making EVs accessible to everyone, today announced its preliminary and unaudited financial results for the fourth quarter and full year ended December 31, 2025.  EV deliveries were 86,557 in the fourth quarter of 2025, representing a 127% increase quarter-over-quarter and a 63% increase year-over-year. Among those, the commercial models under the Green brand and the EC Van model accounted for approximately 49%

    3/16/26 10:43:00 AM ET
    $VFS
    Auto Manufacturing
    Industrials

    FMC Corporation Declares Quarterly Dividend

    PHILADELPHIA, Feb. 27, 2026 /PRNewswire/ -- FMC Corporation (NYSE:FMC) announced today that its board of directors declared a regular quarterly dividend of 8 cents per share, payable on April 16, 2026, to shareholders of record as of the close of business on March 31, 2026. About FMCFMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment. FMC's innovative crop protection solutions – including biologicals, crop nutrition, digital and precision agriculture – enable growers and crop advisers to address their toughest challenges economically while protectin

    2/27/26 5:00:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    $ABL
    $ACON
    $AGFY
    $AJX
    Leadership Updates

    Live Leadership Updates

    View All

    FMC Corporation Announces Election of Michael F. Barry to Board of Directors

    PHILADELPHIA, Feb. 27, 2026 /PRNewswire/ -- FMC Corporation (NYSE:FMC), a leading global agricultural sciences company, today announced the election of Michael F. Barry to the company's Board of Directors, effective February 27, 2026. He will serve on the Audit and Compensation and Human Capital committees.Barry brings more than three decades of global leadership experience in the specialty chemicals industry to FMC's Board. He currently serves as chairman of the Board of Directors of Quaker Houghton and previously served as chief executive officer and president of Quaker Houghton until his retirement in November 2021."We are pleased to welcome Michael to the FMC Board of Directors," said Pi

    2/27/26 4:30:00 PM ET
    $FMC
    Major Chemicals
    Industrials

    Falcon's Beyond Appoints Iraida Que De Vera to Board of Directors

    Falcon's Beyond Global, Inc. (NASDAQ:FBYD) ("Falcon's Beyond", "Falcon's", or the "Company"), a visionary leader in innovative and immersive storytelling today announced the appointment of Iraida Que De Vera to the Company's Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260217898577/en/Iraida Que De Vera, Board Member, Falcon's Beyond Iraida Que De Vera is the Founder and CEO of Amor Maximus, a private family office and strategic advisory platform focused on real estate, capital stewardship, and multigenerational legacy planning. Iraida Que De Vera has built a decades-long career as a top-producing real esta

    2/17/26 4:35:00 PM ET
    $FBYD
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

    CALGARY, Alberta, Feb. 04, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU)), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that further to its press release of October 17, 2025 and an update on December 31, 2025, the Company has entered into an extension agreement with Vectus Biosystems Limited ("Vectus") to allow further time to complete the acquisition of the Renal Anti-Fibrotic Therapeutic Program from Vectus (the "Acquisition"). The term sheet entered into October 17th (the "Term Sheet") to acquire the novel new chemical

    2/4/26 6:00:00 PM ET
    $XRTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABL
    $ACON
    $AGFY
    $AJX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

    SC 13D/A - NewAmsterdam Pharma Co N.V. (0001936258) (Subject)

    12/17/24 5:35:24 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

    SC 13D/A - NewAmsterdam Pharma Co N.V. (0001936258) (Subject)

    12/17/24 4:00:47 PM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by NewAmsterdam Pharma Company N.V.

    SC 13D/A - NewAmsterdam Pharma Co N.V. (0001936258) (Subject)

    12/17/24 10:28:58 AM ET
    $NAMS
    Biotechnology: Pharmaceutical Preparations
    Health Care